Milza 50mg Capsule
By Milza
Rx
10 Capsule in a Strip

Composition
Milnacipran(50mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
June, 2026

liver
Milza 50mg Capsule is considered safe for use in patients with liver disease based on the available data. It is suggested that dose adjustment of Milza 50mg Capsule may not be necessary in these individuals. However, caution is recommended for patients with severe liver disease. It is advisable to consult your doctor before starting the medication, especially if you have any liver concerns.

kidney
Milza 50mg Capsule requires caution in patients with kidney disease. Adjusting the dosage may be necessary. Consult your doctor.

alcohol
When taking Milza 50mg Capsule, be cautious when drinking alcohol. It is recommended to consult your doctor.

driving
When taking Milza 50mg Capsule, be cautious while driving as it may impair your thinking and reactions, affecting your ability to drive.

pregnancy
Milza 50mg Capsule may not be safe to use during pregnancy as animal studies have shown potential harm to the developing baby. Your doctor will carefully consider the benefits and risks before recommending this medication. Please consult your doctor before taking Milza 50mg Capsule during pregnancy.

breastfeeding
Milza 50mg Capsule may not be safe to use during breastfeeding. Limited research indicates it could pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Phenylacetamide Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Serotonin-norepinephrine reuptake inhibitors (SNRIs) |
₹113
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024